News - Seroquel

Filter

Current filters:

Seroquel

Popular Filters

DC Circuit Court says AstraZeneca not entitled to three-year exclusivity for Seroquel

29-04-2013

In a brief opinion handed down last week by the US Court of Appeals for the District of Columbia Circuit,…

AstraZenecaNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel

Significant opportunity remains In unipolar depression market, says DR

30-08-2012

Significant opportunity remains in the unipolar depression market owing to both the high prevalence of…

AbilifyGenericsMarkets & MarketingNeurologicalPharmaceuticalSeroquel

Slow-down of European bipolar therapy market set for short-term slowdown

04-07-2012

Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

US court turns down AstraZeneca FDA injunction; Teva debuts generic Seroquel in UK

26-03-2012

In another setback for Anglo-Swedish drug major AstraZeneca in its fight to delay generic competition…

AstraZenecaEuropeGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalRegulationSeroquelSeroquel XR

AstraZeneca in deal with Galapagos; view on Seroquel law suit

15-03-2012

BioFocus and Argenta, service companies of Netherlands-based Galapagos (Euronext: GLPG), yesterday announced…

Argenta DiscoveryAstraZenecaBioFocusGalapagosLegalNeurologicalPharmaceuticalResearchRespiratory and PulmonarySeroquelSeroquel XR

AstraZeneca sues US FDA over Seroquel decision

13-03-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this morning that it has filed a law suit against…

AstraZenecaLegalNeurologicalNorth AmericaPharmaceuticalRegulationSeroquelSeroquel XR

AstraZeneca Seroquel petitions denied by US FDA

09-03-2012

The US Food and Drug Administration had denied Citizen Petitions filed by Anglo-Swedish drug major AstraZeneca…

AstraZenecaSeroquelSeroquel XR

Back to top